Kevin has over 25 years of experience in the life science industry, covering a wide range of sectors such as drug and vaccine development, biomanufacturing, biomedical imaging and clinical pharmacology. He has been CEO of a number of high growth biotechnology businesses and is currently Chairman of Biorelate Limited, Biotaspheric Limited and ValiRx plc.
Kevin’s non-business roles have included Board membership of the BIA, Chair of BioNow and the Bio/Pharma Advisory Committee of UKTI (now DIT), and membership of various government advisory boards. He is currently a non-executive director of the British Neuroscience Association and sits on an industry advisory board for UoM.
With a passion for improving translational science in the UK, Kevin has developed strong links to academia, funding bodies and government and is keen to improve connectivity across all sectors.
Leonardo Royal Hotel London Tower Bridge16 May 2023